Abstract
The diarrheal disease cholera remains a global threat, but there is limited knowledge of the innate immune defenses in the small intestine that protect against the causative agent, Vibrio cholerae . Here, single-cell RNA-sequencing of epithelial and immune cells mapped gene expression patterns in the infant mouse small intestine and revealed changes in response to V. cholerae infection and prophylactic treatment with an IL22 Fc-fusion protein. Infection increased the abundance of an enterocyte subtype with high expression of defense-associated functions and stimulated production of IL22, a cytokine linked to epithelial integrity, from group 3 innate lymphoid cells. Administration of IL22Fc increased production of vibriocidal Reg3β from enterocytes and the abundance of secretory lineage and Muc2-producing goblet cells, which secreted mucus into the intestinal crypts, impairing V. cholerae association with the epithelium. These IL22-mediated responses limited V. cholerae intestinal colonization and protected mice from diarrhea and death. Our findings suggest enterocyte specialization in mucosal defense. Summary Single cell studies uncovered specialization of epithelial cells in intestinal defense. The epithelial cell-targeting cytokine IL22 protected mice from cholera by promoting the genesis of mucus secreting cells.
Full text
2,057 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
The diarrheal disease cholera remains a global threat. However, knowledge of the innate immune defenses in the small intestine that protect against the causative agent, Vibrio cholerae, is limited. Here, single-cell RNA-sequencing of epithelial and immune cells mapped gene expression patterns in the infant mouse small intestine and revealed changes in response to V. cholerae infection and treatment with an IL22 Fc-fusion protein. Infection increased the abundance of an enterocyte subtype that highly expressed defense-associated functions and stimulated production of IL22, a cytokine linked to epithelial integrity, from group 3 innate lymphoid cells. Administration of IL22Fc increased production of vibriocidal Reg3β from enterocytes and the abundance of secretory lineage and Muc2-producing goblet cells, which secreted mucus into the intestinal crypts, impairing V. cholerae association with the epithelium. These IL22-mediated responses limited V. cholerae intestinal colonization and protected mice from diarrhea and death. These observations suggest enterocyte specialization in mucosal defense, identify mechanisms of IL22-mediated protection, and point to host-directed approaches for cholera therapeutics.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
1)Fate-mapping experiments using Edu and genetically labelled stem cells to decipher the origins of cluster 5 enterocytes, resulting in new Fig. 1h-j and Extended Data Fig.3c-f. Additionally, new RNA velocity analyses of our scRNA-Seq data corroborating the origin of cluster 5 enterocytes. 2)Edu labeling of proliferating cells to uncover how IL22 treatment increases the secretory progenitor cell population, resulting in a new Extended Data Fig. 9. 3)Several experiments, including intestinal proteomics, expand on the mechanisms of protection resulting from IL22 treatment, resulting in new Extended Data Fig. 8c. 4)New evidence using Muc2 -/- mice (new Fig. 6n) linking bacterial motility and mucus-mediated colonization restriction.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.